Mahyar Afshar Mohajer
Mahyar Afshar Mohajer has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Min Zou
Department of Mechanical Engineering, University of Arkansas, Fayetteville, AR 72701, USA
2 shared publications A.R. Bushroa
1 shared publicationAlan Woessner
Department of Biomedical Engineering, College of Engineering, University of Arkansas, Fayetteville, Arkansas 72701, United States
1 shared publicationAlex Steuber
Department of Chemistry and Biochemistry
1 shared publication- Alireza Yaghoubi
Australian Centre for Advanced Photovoltaics School of Photovoltaic and Renewable Energy Engineering University of New South Wales Sydney NSW 2052 Australia
1 shared publication - Anne Lobitz
Department of Civil Engineering
1 shared publication
Latest Publications
- Open Access
- 4 November 2025
- Published by American Chemical Society (ACS) in ACS ES&T Water
- Vol. 5 (11) , 6633-6643
Fluorous Modification of Commercial Resins for Ultrashort and Short Chain PFAS Removal
- 4 November 2025
- Published by American Chemical Society (ACS) in ACS ES&T Water
- Vol. 5 (11) , 6633-6643
Open AccessFluorous Modification of Commercial Resins for Ultrashort and Short Chain PFAS Removal
- 3 September 2024
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 18 (37) , 25716-25739
A Multicomponent Microneedle Patch for the Delivery of Meloxicam for Veterinary Applications
This study evaluates the use of poly(vinyl alcohol), collagen, and chitosan blends for developing a microneedle patch for the delivery of meloxicam (MEL). Results confirm successful MEL encapsulation, structural integrity, and chemical stability even after ethylene oxide sterilization. Mechanical testing indicates the patch has the required properties for effective skin penetration and drug delivery, as demonstrated by load-displacement curves showing successful penetration of pig ear surfaces at 3N of normal load. In vitro imaging confirms the microneedle patch penetrates the pig's ear cadaver skin effectively and uniformly, with histological evaluation revealing the sustained presence and gradual degradation of microneedles within the skin. Additionally, in vitro drug diffusion experiments utilizing ballistic gel suggest that microneedles commence dissolution almost immediately upon insertion into the gel, steadily releasing the drug over 24 h. Furthermore, the microneedle patch demonstrates ideal drug release capabilities, achieving nearly 100% release of meloxicam content from a single patch within 18 h. Finally, in vivo studies using pigs demonstrate the successful dissolution and transdermal drug delivery efficacy of biodegradable microneedle patches delivering meloxicam in a porcine model, with over 70% of microneedles undergoing dissolution after 3 days. While low detectable meloxicam concentrations were observed in the bloodstream, high levels were detected in the ear tissue, confirming the release and diffusion of the drug from microneedles. This work highlights the potential of microneedle patches for controlled drug release in veterinary applications.
- 3 September 2024
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 18 (37) , 25716-25739
A Multicomponent Microneedle Patch for the Delivery of Meloxicam for Veterinary Applications
This study evaluates the use of poly(vinyl alcohol), collagen, and chitosan blends for developing a microneedle patch for the delivery of meloxicam (MEL). Results confirm successful MEL encapsulation, structural integrity, and chemical stability even after ethylene oxide sterilization. Mechanical testing indicates the patch has the required properties for effective skin penetration and drug delivery, as demonstrated by load-displacement curves showing successful penetration of pig ear surfaces at 3N of normal load. In vitro imaging confirms the microneedle patch penetrates the pig's ear cadaver skin effectively and uniformly, with histological evaluation revealing the sustained presence and gradual degradation of microneedles within the skin. Additionally, in vitro drug diffusion experiments utilizing ballistic gel suggest that microneedles commence dissolution almost immediately upon insertion into the gel, steadily releasing the drug over 24 h. Furthermore, the microneedle patch demonstrates ideal drug release capabilities, achieving nearly 100% release of meloxicam content from a single patch within 18 h. Finally, in vivo studies using pigs demonstrate the successful dissolution and transdermal drug delivery efficacy of biodegradable microneedle patches delivering meloxicam in a porcine model, with over 70% of microneedles undergoing dissolution after 3 days. While low detectable meloxicam concentrations were observed in the bloodstream, high levels were detected in the ear tissue, confirming the release and diffusion of the drug from microneedles. This work highlights the potential of microneedle patches for controlled drug release in veterinary applications.
- 1 July 2014
- Published by Elsevier in Applied Surface Science
- Vol. 307, 1-6
Electrophoretic deposition of magnesium silicates on titanium implants: Ion migration and silicide interfaces
- 1 July 2014
- Published by Elsevier in Applied Surface Science
- Vol. 307, 1-6
Electrophoretic deposition of magnesium silicates on titanium implants: Ion migration and silicide interfaces